Does SECUKINUMAB Cause Skin lesion? 1,909 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,909 reports of Skin lesion have been filed in association with SECUKINUMAB (COSENTYX). This represents 1.3% of all adverse event reports for SECUKINUMAB.
1,909
Reports of Skin lesion with SECUKINUMAB
1.3%
of all SECUKINUMAB reports
17
Deaths
275
Hospitalizations
How Dangerous Is Skin lesion From SECUKINUMAB?
Of the 1,909 reports, 17 (0.9%) resulted in death, 275 (14.4%) required hospitalization, and 29 (1.5%) were considered life-threatening.
Is Skin lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 1,909 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Skin lesion?
ADALIMUMAB (1,507)
METHOTREXATE (1,237)
DUPILUMAB (685)
ETANERCEPT (647)
PREDNISONE (617)
TOFACITINIB (478)
INFLIXIMAB (474)
CYCLOSPORINE (380)
LENALIDOMIDE (369)
TACROLIMUS (366)
Which SECUKINUMAB Alternatives Have Lower Skin lesion Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG